Molecular evidence for BDNF- and GABA-related dysfunctions in the amygdala of female subjects with Major Depression
暂无分享,去创建一个
G. Tseng | E. Sibille | K. Martinowich | Xingbin Wang | J. Guilloux | A. Gardier | Rama S. Kota | D. Lewis | G. Douillard-Guilloux
[1] H. M. Morris,et al. GABA-related transcripts in the dorsolateral prefrontal cortex in mood disorders. , 2011, The international journal of neuropsychopharmacology.
[2] M. Webster,et al. Decreased BDNF, trkB-TK+ and GAD67 mRNA expression in the hippocampus of individuals with schizophrenia and mood disorders. , 2011, Journal of psychiatry & neuroscience : JPN.
[3] E. Sibille,et al. Integrated behavioral z-scoring increases the sensitivity and reliability of behavioral phenotyping in mice: Relevance to emotionality and sex , 2011, Journal of Neuroscience Methods.
[4] E. Sibille,et al. Reduced somatostatin in subgenual anterior cingulate cortex in major depression , 2011, Neurobiology of Disease.
[5] R. Yuste,et al. Dense Inhibitory Connectivity in Neocortex , 2011, Neuron.
[6] S. Langenecker,et al. Emotion processing, major depression, and functional genetic variation of neuropeptide Y. , 2011, Archives of general psychiatry.
[7] N. Pivac,et al. The association between brain-derived neurotrophic factor polymorphism (BDNF Val66Met) and suicide. , 2011, Journal of affective disorders.
[8] Etienne Sibille,et al. Brain molecular aging, promotion of neurological disease and modulation by Sirtuin5 longevity gene polymorphism , 2011, Neurobiology of Disease.
[9] Daniel S Pine,et al. BDNF gene polymorphism (Val66Met) predicts amygdala and anterior hippocampus responses to emotional faces in anxious and depressed adolescents , 2010, NeuroImage.
[10] K. Sakata,et al. Lack of promoter IV‐driven BDNF transcription results in depression‐like behavior , 2010, Genes, brain, and behavior.
[11] B. Penninx,et al. Serum levels of brain-derived neurotrophic factor in major depressive disorder: state–trait issues, clinical features and pharmacological treatment , 2010, Molecular Psychiatry.
[12] M. Leboyer,et al. A SNAP25 promoter variant is associated with early-onset bipolar disorder and a high expression level in brain , 2010, Molecular Psychiatry.
[13] C. Gaiteri,et al. Altered Gene Synchrony Suggests a Combined Hormone-Mediated Dysregulated State in Major Depression , 2010, PloS one.
[14] F. Holsboer,et al. A novel chronic social stress paradigm in female mice , 2010, Hormones and Behavior.
[15] Paul B. Fitzgerald,et al. Evidence of Cortical Inhibitory Deficits in Major Depressive Disorder , 2010, Biological Psychiatry.
[16] V. Carli,et al. Increased BDNF promoter methylation in the Wernicke area of suicide subjects. , 2010, Archives of general psychiatry.
[17] P. Czobor,et al. Association study of NRG1, DTNBP1, RGS4, G72/G30, and PIP5K2A with schizophrenia and symptom severity in a Hungarian sample , 2009, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[18] C. Belzung,et al. Deficit in BDNF does not increase vulnerability to stress but dampens antidepressant-like effects in the unpredictable chronic mild stress , 2009, Behavioural Brain Research.
[19] David A Lewis,et al. A molecular signature of depression in the amygdala. , 2009, The American journal of psychiatry.
[20] J. Deakin,et al. Expression of hippocampal brain-derived neurotrophic factor and its receptors in Stanley consortium brains. , 2009, Journal of psychiatric research.
[21] E. Sibille,et al. The roles of sex and serotonin transporter levels in age- and stress-related emotionality in mice , 2009, Brain Research.
[22] W. Bunney,et al. Global Brain Gene Expression Analysis Links Glutamatergic and GABAergic Alterations to Suicide and Major Depression , 2009, PloS one.
[23] Kenji F. Tanaka,et al. Synergistic neurochemical and behavioural effects of acute intrahippocampal injection of brain-derived neurotrophic factor and antidepressants in adult mice. , 2009, The international journal of neuropsychopharmacology.
[24] L. Monteggia,et al. Gender-Specific Impact of Brain-Derived Neurotrophic Factor Signaling on Stress-Induced Depression-Like Behavior , 2009, Biological Psychiatry.
[25] E. Cattaneo,et al. Brain-derived neurotrophic factor in neurodegenerative diseases , 2009, Nature Reviews Neurology.
[26] J. Hensler,et al. Gender differences in the enhanced vulnerability of BDNF+/- mice to mild stress. , 2009, The international journal of neuropsychopharmacology.
[27] E. Sibille,et al. Corticolimbic Transcriptome Changes are State-Dependent and Region-Specific in a Rodent Model of Depression and of Antidepressant Reversal , 2009, Neuropsychopharmacology.
[28] Keri Martinowich,et al. Critical role of promoter IV-driven BDNF transcription in GABAergic transmission and synaptic plasticity in the prefrontal cortex , 2009, Proceedings of the National Academy of Sciences.
[29] C. Dickson,et al. Anxiolytic and antidepressant effects of intracerebroventricularly administered somatostatin: Behavioral and neurophysiological evidence , 2008, Neuroscience.
[30] R. Duman,et al. Serum Brain-Derived Neurotrophic Factor, Depression, and Antidepressant Medications: Meta-Analyses and Implications , 2008, Biological Psychiatry.
[31] H. M. Morris,et al. Alterations in somatostatin mRNA expression in the dorsolateral prefrontal cortex of subjects with schizophrenia or schizoaffective disorder. , 2008, Cerebral cortex.
[32] J. P. Hamilton,et al. Neural Substrates of Increased Memory Sensitivity for Negative Stimuli in Major Depression , 2008, Biological Psychiatry.
[33] F. Broekmans,et al. Relationship of serum antimüllerian hormone concentration to age at menopause. , 2008, The Journal of clinical endocrinology and metabolism.
[34] E. Roubos,et al. Gender-related urocortin 1 and brain-derived neurotrophic factor expression in the adult human midbrain of suicide victims with major depression , 2008, Neuroscience.
[35] Ahmad R. Hariri,et al. Genetic variation in human NPY expression affects stress response and emotion , 2008, Nature.
[36] A. Meyer-Lindenberg,et al. Evidence of biologic epistasis between BDNF and SLC6A4 and implications for depression , 2008, Molecular Psychiatry.
[37] D. Lewis,et al. Large-scale estimates of cellular origins of mRNAs: Enhancing the yield of transcriptome analyses , 2008, Journal of Neuroscience Methods.
[38] Tamara Aid,et al. Dissecting the human BDNF locus: Bidirectional transcription, complex splicing, and multiple promoters☆ , 2007, Genomics.
[39] Peter F. Buckley,et al. Neurotrophins and schizophrenia , 2007, Schizophrenia Research.
[40] R Hen,et al. Lack of serotonin1B receptor expression leads to age-related motor dysfunction, early onset of brain molecular aging and reduced longevity , 2007, Molecular Psychiatry.
[41] F. Mascagni,et al. Postsynaptic targets of somatostatin‐containing interneurons in the rat basolateral amygdala , 2007, The Journal of comparative neurology.
[42] Serge Nef,et al. Brain-Derived Neurotrophic Factor Conditional Knockouts Show Gender Differences in Depression-Related Behaviors , 2007, Biological Psychiatry.
[43] M. Thase,et al. Increased Amygdala and Decreased Dorsolateral Prefrontal BOLD Responses in Unipolar Depression: Related and Independent Features , 2007, Biological Psychiatry.
[44] Wim E Crusio,et al. Effects of unpredictable chronic mild stress on anxiety and depression-like behavior in mice , 2006, Behavioural Brain Research.
[45] D. Lewis,et al. Specificity and timing of neocortical transcriptome changes in response to BDNF gene ablation during embryogenesis or adulthood , 2006, Molecular Psychiatry.
[46] R. Duman,et al. A Neurotrophic Model for Stress-Related Mood Disorders , 2006, Biological Psychiatry.
[47] E. Nestler,et al. Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action , 2006, Nature Neuroscience.
[48] A. Børresen-Dale,et al. Gene expression profiling of whole-blood samples from women exposed to hormone replacement therapy , 2006, Molecular Cancer Therapeutics.
[49] Danielle L. Graham,et al. Essential Role of BDNF in the Mesolimbic Dopamine Pathway in Social Defeat Stress , 2006, Science.
[50] M. Whitlock. Combining probability from independent tests: the weighted Z‐method is superior to Fisher's approach , 2005, Journal of evolutionary biology.
[51] M. Schwald,et al. Neurotrophin levels in postmortem brains of suicide victims and the effects of antemortem diagnosis and psychotropic drugs. , 2005, Brain research. Molecular brain research.
[52] V. Arango,et al. Molecular aging in human prefrontal cortex is selective and continuous throughout adult life , 2005, Biological Psychiatry.
[53] J. Bizot,et al. Strain differences in sucrose preference and in the consequences of unpredictable chronic mild stress , 2004, Behavioural Brain Research.
[54] N. Schork,et al. Candidate genes, pathways and mechanisms for bipolar (manic–depressive) and related disorders: an expanded convergent functional genomics approach , 2004, Molecular Psychiatry.
[55] Stuart Maudsley,et al. A neural signaling triumvirate that influences ageing and age-related disease: insulin/IGF-1, BDNF and serotonin , 2004, Ageing Research Reviews.
[56] B. Ravnkilde,et al. Hippocampal volume and depression: a meta-analysis of MRI studies. , 2004, The American journal of psychiatry.
[57] M. Barrot,et al. Essential role of brain-derived neurotrophic factor in adult hippocampal function. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[58] John H Krystal,et al. Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression. , 2004, Archives of general psychiatry.
[59] Anthony R. McIntosh,et al. Limbic–frontal circuitry in major depression: a path modeling metanalysis , 2004, NeuroImage.
[60] Michael Marriott,et al. Lower hippocampal volume in patients suffering from depression: a meta-analysis. , 2004, The American journal of psychiatry.
[61] J. Price,et al. Glial reduction in amygdala in major depressive disorder is due to oligodendrocytes , 2004, Biological Psychiatry.
[62] R Hashimoto,et al. Expression analysis of neuregulin-1 in the dorsolateral prefrontal cortex in schizophrenia , 2004, Molecular Psychiatry.
[63] B. Zörner,et al. Mice with reduced brain-derived neurotrophic factor expression show decreased choline acetyltransferase activity, but regular brain monoamine levels and unaltered emotional behavior. , 2004, Brain research. Molecular brain research.
[64] R. Hen,et al. Requirement of Hippocampal Neurogenesis for the Behavioral Effects of Antidepressants , 2003, Science.
[65] Yogesh K. Dwivedi,et al. Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects. , 2003, Archives of general psychiatry.
[66] A. Sampson,et al. Gene Expression Deficits in a Subclass of GABA Neurons in the Prefrontal Cortex of Subjects with Schizophrenia , 2003, The Journal of Neuroscience.
[67] E. Castrén,et al. Activation of the TrkB Neurotrophin Receptor Is Induced by Antidepressant Drugs and Is Required for Antidepressant-Induced Behavioral Effects , 2003, The Journal of Neuroscience.
[68] J. Price,et al. Low glial numbers in the amygdala in major depressive disorder , 2002, Biological Psychiatry.
[69] R. Duman,et al. Brain-Derived Neurotrophic Factor Produces Antidepressant Effects in Behavioral Models of Depression , 2002, The Journal of Neuroscience.
[70] S. Fatemi,et al. Altered levels of the synaptosomal associated protein SNAP-25 in hippocampus of subjects with mood disorders and schizophrenia , 2001, Neuroreport.
[71] G. MacQueen,et al. Increased hippocampal bdnf immunoreactivity in subjects treated with antidepressant medication , 2001, Biological Psychiatry.
[72] Y. Benjamini,et al. THE CONTROL OF THE FALSE DISCOVERY RATE IN MULTIPLE TESTING UNDER DEPENDENCY , 2001 .
[73] George Paxinos,et al. The Mouse Brain in Stereotaxic Coordinates , 2001 .
[74] R. Paylor,et al. Impairment in motor learning of somatostatin null mutant mice , 2001, Brain Research.
[75] R. Kerwin,et al. Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder. , 2001, Archives of general psychiatry.
[76] L. Selemon,et al. Reductions in neuronal and glial density characterize the dorsolateral prefrontal cortex in bipolar disorder , 2001, Biological Psychiatry.
[77] D. Lewis,et al. Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia , 2001, Molecular Psychiatry.
[78] A. Sampson,et al. Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia. , 2000, Archives of general psychiatry.
[79] Fahmeed Hyder,et al. Reduced Cortical γ-Aminobutyric Acid Levels in Depressed Patients Determined by Proton Magnetic Resonance Spectroscopy , 1999 .
[80] C. Cotman,et al. Exercise, Antidepressant Medications, and Enhanced Brain Derived Neurotrophic Factor Expression , 1999, Neuropsychopharmacology.
[81] F. Bloom,et al. The Central 5-HT3 Receptor in CNS Disorders , 1998, Neurochemical Research.
[82] L. Glantz,et al. Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia. Regional and diagnostic specificity. , 1997, Archives of general psychiatry.
[83] Yasuhisa Endo,et al. Brain‐Derived Neurotrophic Factor Increases the Stimulation‐Evoked Release of Glutamate and the Levels of Exocytosis‐Associated Proteins in Cultured Cortical Neurons from Embryonic Rats , 1997, Journal of neurochemistry.
[84] T Bonhoeffer,et al. Hippocampal long-term potentiation is impaired in mice lacking brain-derived neurotrophic factor. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[85] M J Campbell,et al. An immunohistochemical characterization of somatostatin‐28 and somatostatin‐281–12 in monkey prefrontal cortex , 1986, The Journal of comparative neurology.
[86] Denis Dooley,et al. Atlas of the Human Brain. , 1971 .
[87] Serum BDNF concentrations in major depressive disorder: state-trait issues, clinical features and pharmacological treatment , 2014 .
[88] J. Ávila,et al. Expression of Somatostatin, cortistatin, and their receptors, as well as dopamine receptors, but not of neprilysin, are reduced in the temporal lobe of Alzheimer's disease patients. , 2010, Journal of Alzheimer's disease : JAD.
[89] Neil A. Ernst,et al. Alternative splicing, methylation state, and expression profile of tropomyosin-related kinase B in the frontal cortex of suicide completers. , 2009, Archives of general psychiatry.
[90] R A Bryant,et al. Interactions between BDNF Val66Met polymorphism and early life stress predict brain and arousal pathways to syndromal depression and anxiety , 2009, Molecular Psychiatry.
[91] V. Dumeaux,et al. Gene expression profiling in whole-blood samples from postmenopausal women exposed to hormone replacement therapy , 2005, Breast Cancer Research.
[92] G F Mason,et al. Reduced cortical gamma-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy. , 1999, Archives of general psychiatry.
[93] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .